Connected profileLeuprolide
Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
leuprolide clinical trials
8 selected ClinicalTrials.gov records carrying the official matched intervention leuprolide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
Registry records
8 selected records.
Connected peptides
1 profiles.
Source boundary
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 46 selected PubMed records and 24 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
Record added
ClinicalTrials.gov record NCT00004344
PeptideScanner retained ClinicalTrials.gov record NCT00004344 at 2026-07-30T22:50:58.186Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- June 24, 2005
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00004426
PeptideScanner retained ClinicalTrials.gov record NCT00004426 at 2026-07-30T21:43:54.469Z. Its registry update date was 2015-03-26, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- March 26, 2015
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00004436
PeptideScanner retained ClinicalTrials.gov record NCT00004436 at 2026-07-30T21:43:54.456Z. Its registry update date was 2015-03-25, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- March 25, 2015
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Leuprolide · 2018-01-23
ClinicalTrials.gov record NCT01116401
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-04-18
ClinicalTrials.gov record NCT00903162
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-03-26
ClinicalTrials.gov record NCT00004426
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-03-25
ClinicalTrials.gov record NCT00004436
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-03-25
ClinicalTrials.gov record NCT00004438
Completed at the retained observation.
Open attributed record →Leuprolide · 2014-05-15
ClinicalTrials.gov record NCT01088529
Completed at the retained observation.
Open attributed record →Leuprolide · 2005-06-24
ClinicalTrials.gov record NCT00004344
Completed at the retained observation.
Open attributed record →Leuprolide · 2005-06-24
ClinicalTrials.gov record NCT00004771
Completed at the retained observation.
Open attributed record →